New Zealand markets closed

a.k.a. Brands Holding Corp. (AKA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
11.18-0.38 (-3.29%)
At close: 03:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 121.39M
Enterprise value 235.78M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.23
Price/book (mrq)0.82
Enterprise value/revenue 0.43
Enterprise value/EBITDA -3.54

Trading information

Stock price history

Beta (5Y monthly) 1.66
52-week change 3148.92%
S&P500 52-week change 321.23%
52-week high 314.28
52-week low 33.60
50-day moving average 310.62
200-day moving average 38.02

Share statistics

Avg vol (3-month) 37.24k
Avg vol (10-day) 37.95k
Shares outstanding 510.5M
Implied shares outstanding 610.5M
Float 8960.12k
% held by insiders 135.94%
% held by institutions 155.51%
Shares short (28 Mar 2024) 477.6k
Short ratio (28 Mar 2024) 411.35
Short % of float (28 Mar 2024) 411.56%
Short % of shares outstanding (28 Mar 2024) 40.74%
Shares short (prior month 29 Feb 2024) 491.24k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 302 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -18.10%
Operating margin (ttm)-3.62%

Management effectiveness

Return on assets (ttm)-2.14%
Return on equity (ttm)-49.98%

Income statement

Revenue (ttm)546.26M
Revenue per share (ttm)51.02
Quarterly revenue growth (yoy)-0.10%
Gross profit (ttm)N/A
EBITDA 4.26M
Net income avi to common (ttm)-98.89M
Diluted EPS (ttm)-9.24
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)21.86M
Total cash per share (mrq)2.08
Total debt (mrq)136.25M
Total debt/equity (mrq)91.68%
Current ratio (mrq)1.58
Book value per share (mrq)14.06

Cash flow statement

Operating cash flow (ttm)33.43M
Levered free cash flow (ttm)41.59M